overview of changes from dsm iv- tr to dsm 5 and their implications for the gain-i barbara estrada,...

23
Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN Coordinating Center

Upload: samara-chard

Post on 15-Dec-2015

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN

Overview of Changes from DSM IV-TR to DSM 5 and Their Implications for the GAIN-I

Barbara Estrada, MSGAIN Senior Clinical and Evaluation Consultant

GAIN Coordinating Center

Page 2: Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN

Purpose

This webinar will provide attendees a description of the substantive changes from DSM IV-TR to DSM-5 and how the GAIN Coordinating Center plans to address them in the GAIN-I and clinical reports.

Your feedback is important!

Page 3: Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN

Overview• The DSM IV diagnostic codes were replaced

with a new set of codes that map onto ICD-9. • The GAIN is being updated to allow clinicians

to switch back and forth between DSM-IV and DSM-5 at will.

Page 4: Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN

Multi-Axial System

• The multi-axial system was removed in DSM-5 in favor of collapsing Axis I and II into just diagnosis and the remaining axis’s into other conditions. – In the GRRS and ICP the heading "DSM-IV/ICD-9

Diagnosis" and "Axis I-V" headings are replaced by "DSM-5/ICD-9 (ICD-10) Diagnosis" (formerly Axis I and II), "DSM-5/ICD-9 (ICD-10) Other Conditions That May Be a Focus of Clinical Attention" (formerly Axis III through IV).

– DSM-5 eliminated the old Axis V, but did recommend a new optional scale discussed further below.

DSM 5 pp. xxxiv, 16

Page 5: Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN

Abuse and Dependence

• Within “Substance Use Disorders”, the “Substance Abuse” and “Substance Dependence” diagnoses were replaced with "Substance Use Disorder -mild (2-3 symptoms), -moderate (4-5 symptoms), or –severe (6-11 symptoms)." These changes were made throughout the clinical reports.

DSM 5 pp. 484, 482-577

Page 6: Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN

Substance Use Disorders

• DSM-5 includes a new substance use disorder criterion regarding craving. We add two new items. S9ua "When was the last time that you had such strong urges to use alcohol or other drugs you could not think of anything else?" and S9ua1-99 in the S9 matrix "you had such strong urges to use you could not think of anything else?"

+DSM 5 pp. 483, 482-577

Page 7: Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN

Substance Use Disorders

• DSM-5 dropped the substance use criterion "recurrent substance-related legal problems (e.g., arrests for substance-related disorderly conduct)" because it was associated with social injustice as much as individual severity. For scoring purposes in DSM-5, this criterion was dropped for all substances in S9 matrix (S9k, S9k1-99).

• The item, however, was retained to allow clinicians to switch between DSM-IV (which requires it) and DSM-5. -

DSM 5 pp. 483, 482-577

Page 8: Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN

Cannabis Withdrawal

• DSM-5 added cannabis withdrawal symptoms as endorsing 3 or more of 1) Irritability, anger, or aggression, 2) Nervousness or anxiety, 3) Sleep difficulty, 4) Decreased appetite or weight loss, 5) Restlessness, 6) Depressed mood , and 7) Physical discomfort.

• We added two new withdrawal symptoms to for cannabis withdrawal: Irritability, anger, or aggression (new item S3c20), and depressed mood (S3c21). The other symptoms were already in the GAIN.+

DSM 5 pp. 484, 482-577

Page 9: Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN

Tobacco Use Disorder

• DSM-5 replaced “Tobacco dependence” with tobacco use disorder (mild, moderate, severe).

• These new questions match the criteria for other drugs currently in the GAIN and the exact wording of the new craving item.

• We add four items for tobacco use. R1ch: repeatedly caused you not to meet your responsibilities, R1cj: you repeatedly used in unsafe situations, R1cm: did you keep using even though it was leading to fights or getting you into trouble with other people, R1ua: When was the last time that you had such strong urges to take the drug that you could not think of anything else.

DSM 5 pp. 571

Page 10: Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN

Specifiers

Changes to specifiers were made throughout the clinical reports to account for DSM-5 changes:• Removal of specifiers "with physiological

symptoms” and "without physiological symptoms." The remission specifiers were deleted.

• Remission specifiers "Sustained Partial Remission" and "Sustained Full Remission" replaced with "In Sustained Remission". The remission specifiers were changed.

DSM 5 pp. 484, 482-577

Page 11: Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN

Specifiers

Changes to specifiers were made throughout the clinical reports to account for DSM-5 changes:• Remission specifiers "Early Partial Remission" and "Early

Full Remission" replaced with "In Early Remission,” the timeframe for early remission was changed to from 1 month to 3 months and added the exception for craving. The remission specifiers were changed. To allow for either the DSM-IV or 5 timeframes for early remission, we changed the S9 response set to Past Month, 2 to 3 Months Ago, 4 to 12 Months Ago, 1-3 Years Ago, More than 3 Years Ago, and Never.

DSM 5 pp. 484, 482-577

Page 12: Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN

Substance Class Changes

Substance/Class Changes were made throughout the clinical reports to account for new DSM-5 classification:• Amphetamine and Cocaine were collapsed into

Stimulant Use Disorder • PCP was collapsed into Hallucinogen Use Disorder. • All substance use disorders allow specification of

primary form of a drug used within a class (e.g., Amphetamine, Methamphetamine, Cocaine, Crack, PCP, OxyContin)

DSM 5 pp. 520, 561

Page 13: Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN

Major Depressive Disorder

• According to DSM-5 Major Depressive Disorder includes a new symptom, "Feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) nearly every day (not merely self-reproach or guilt about being sick).” We added a new item (M1b13) "Feeling worthless or that the bad things that have happened in your life are your fault.”

• The item was simplified from the DSM-5 symptom for ease of administration.+

DSM 5 pp. 160

Page 14: Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN

Gambling Disorder

• DSM-5 has renamed "Pathological Gambling" to "Gambling Disorder".

• The criterion “paid for your gambling with bad checks, someone else's money, or with something that didn't belong to you” no longer included in diagnostic criteria for DSM-5 and we changed the terminology throughout the reports.

• Item V9h was kept to allow clinicians to switch between DSM-IV and DSM-5.

-DSM 5 pp. 585

Page 15: Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN

ADHD

DSM-5 included several changes to ADHD which we have made:• "Attention Deficit Hyperactive Disorder - Combined

Type" changed to "Attention-Deficit/Hyperactivity Disorder - Combined presentation". Criterion changed to up to age 16 requires 6 or more inattention symptoms and 6 or more hyperactivity/ impulsivity symptoms; age 17 and older requires 5 or more inattention symptoms and 5 or more hyperactivity/impulsivity symptoms.

DSM 5 pp. 59-66

Page 16: Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN

ADHD

• “Attention Deficit Hyperactive Disorder - Inattentive Type" changed to "Attention-Deficit/Hyperactivity Disorder - Predominantly inattentive presentation". Criterion changed to up to age 16 requires 6 or more inattention symptoms; age 17 and older requires 5 or more inattention symptoms.

DSM 5 pp. 59-66

Page 17: Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN

ADHD

• "Attention Deficit Hyperactive Disorder - Hyperactive Type" changed to "Attention-Deficit/Hyperactivity Disorder - Predominantly Hyperactive/Impulsive Presentation”. Criterion changed to up to age 16 requires 6 or more hyperactivity/impulsivity symptoms; age 17 and older requires 5 or more hyperactivity/impulsivity symptoms.

• ADHD age of on-set criteria raised form age 7 to 15. The higher ages of onset is still allowed as provisional.

DSM 5 pp. 59-66

Page 18: Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN

NOS/Rule Outs

• DSM-5 Replaced "Not Otherwise Specified" to "Unspecified”, and "Rule Out" to "Provisional". These changes were made throughout the clinical reports.

DSM 5 pp. 15

Page 19: Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN

Axis III and IV

• DSM-5 recommends the use of V Codes from ICD-9-CM or Z codes from ICD-10-CM for previous sections for Axis III and IV. We have included appropriate V codes and Z codes to describe client self-report where possible. However, the previous list of psychosocial problems will also print in the clinical reports.

DSM 5 pp. 16

Page 20: Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN

Axis V

• DSM-5 dropped Axis V GAF . • DSM-5 recommends use of WHODAS 7 General Disability

Score in order to provide a global measure of disability. We have added 8 items (XDSM5g-q) at the end of the GAIN and in the GRRS and ICP section “Other Conditions that May be a Focus of Clinical Attention.”

• The items correspond to the 7 subscale and total score for the WHODAS 7 General Disability Scores (Understanding and communicating, Getting around, Self-care, Setting along with people, Life activities-Household, Life activities-school/work, Participating in society, and Total).

DSM 5 pp. 16, 734, 745-748

Page 22: Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN

Timeline

• GAIN User input: NOW• GAIN-I DSM 5 Instrument Development• Clinical Reports Development• Training materials (Administration, GAIN

Clinical Interpretation, Manual, website, etc.)• Launch

Page 23: Overview of Changes from DSM IV- TR to DSM 5 and Their Implications for the GAIN-I Barbara Estrada, MS GAIN Senior Clinical and Evaluation Consultant GAIN

We are all ears! Discussion and questions